Related Experiment Videos
Isocapnic hyperpnea accelerates carbon monoxide elimination.
J A Fisher1, J Rucker, L Z Sommer
1Department of Anaesthesia, University of Toronto, Toronto; and Department of Physiology, Queens University, Kingston, Ontario, Canada. joe.fisher@utoronto.ca
Summary
Isocapnic hyperpnea significantly accelerates the elimination of carboxyhemoglobin (COHb) during oxygen therapy for carbon monoxide poisoning. This method enhances COHb reduction compared to standard oxygen treatments, improving treatment efficacy.
Area of Science:
- Medical Research
- Toxicology
- Physiology
Background:
- Carbon monoxide (CO) poisoning treatment is often limited by hypocapnia or CO2 discomfort during hyperpnea.
- Carboxyhemoglobin (COHb) levels indicate the severity and duration of CO poisoning.
Purpose of the Study:
- To evaluate the impact of nonrebreathing isocapnic hyperpnea on the rate of COHb elimination.
- To determine if isocapnic hyperpnea improves upon standard oxygen therapy for CO poisoning.
Main Methods:
- The study used pentobarbital-anesthetized dogs exposed to CO and ventilated under various conditions.
- Measurements included blood gases and COHb levels during normocapnia, 100% O2 ventilation, and isocapnic hyperpnea (6x control ventilation).
- Half-time for COHb elimination (t1/2) was calculated for each condition.
Main Results:
- The t1/2 for COHb elimination was 212 min on room air and 42 min on 100% O2 at control ventilation.
- Isocapnic hyperpnea reduced the t1/2 to 18 min, a statistically significant improvement (p < 0.0005).
- Hyperbaric oxygen therapy yielded t1/2 values of 20-28 min.
Conclusions:
- Isocapnic hyperpnea more than doubles the rate of COHb elimination induced by 100% O2 ventilation.
- This technique offers a potential improvement to standard CO poisoning treatments, including those using hyperbaric oxygen.
- Isocapnic hyperpnea may enhance the efficacy of CO poisoning treatment by accelerating COHb clearance.